ON-01910.Na

ON-01910 sodium

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for ON-01910.Na, covering 2013-01-08 to 2020-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts [Phase 3]